Myriad Genetics Inc
(LTS:0K3W)
$
13.635
0.293 (2.19%)
Market Cap: 1.24 Bil
Enterprise Value: 1.29 Bil
PE Ratio: 0
PB Ratio: 1.70
GF Score: 63/100 Myriad Genetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021 / 12:50PM GMT
Release Date Price:
$28.97
(+7.17%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Good morning, everyone, and welcome to the third and final day of the Goldman Sachs Healthcare Conference. I'm Matt Sykes, the Senior Life Sciences Tools & Diagnostics analyst here at Goldman. And we have the pleasure of welcoming Myriad Genetics' management team here. We have Paul Diaz, the President and Chief Executive Officer; and Bryan Riggsbee, the Chief Financial Officer.
Paul, Bryan, thanks so much for being with us today.
Paul J. Diaz
Myriad Genetics, Inc. - CEO, President & Director
Thank you, Matt.
R. Bryan Riggsbee
Myriad Genetics, Inc. - Executive VP, CFO & Treasurer
Thanks for having us.
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Maybe, Paul, I'll turn it over to you first and kind of let you set the stage and just go over a couple of the key highlights for investors
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot